Retatrutide is generally safe for adults who meet the eligibility criteria, but it is not recommended for people with certain medical conditions, such as thyroid cancer history or pancreatitis
Over time, regular drinking alters metabolism, promotes visceral fat storage, and increases insulin resistance
Cardiovascular Risk Markers TRIUMPH-4 also assessed a panel of cardiometabolic biomarkers, and the results were broadly favorable across the board: Non-HDL cholesterol significant reductions, indicating improved atherogenic lipid burden Triglycerides meaningful decreases, consistent with the known effects of GLP-1 and GIP receptor activation on lipid metabolism High-sensitivity C-reactive protein (hsCRP) substantial reductions, reflecting decreased systemic inflammation
This is the same pathway activated by naturally occurring GLP-1 released from your gut after eating
No need to obsess over numbers
Phase 3 TRIUMPH trials ongoing as of 2026